16/05/23 | 15:11 | | MILESTONE MEDICAL: Commencing sales of CompuFlo Epidural disposables within The Pain and Rehabilitation Medical Group in Torrance, California |
10/05/23 | 14:43 | | MILESTONE MEDICAL: Successful completion of epidural steroid injections (ESI) using the CompuFlo Epidural System Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery |
09/05/23 | 15:14 | | MILESTONE MEDICAL: Commencing sales of CompuFlo Epidural disposables within the Sports and Spine Clinic in Oregon |
27/03/23 | 18:15 | | GPW: w sprawie upomnienia spółki MILESTONE MEDICAL. INC. |
22/03/23 | 00:13 | | MILESTONE MEDICAL INC. (2/2023) Consolidated Annual Report for year ended December 31, 2022 |
14/03/23 | 14:31 | | MILESTONE MEDICAL: Commencing sales of CompuFlo Epidural disposables within the University Pain and Spine Center which operates 7 locations across New Jersey and New York |
10/03/23 | 15:15 | | MILESTONE MEDICAL: Commencing sales of CompuFlo Epidural disposables within three Colorado pain management clinics |
02/03/23 | 15:06 | | MILESTONE MEDICAL: The registration of CompuFlo Epidural System with the U.S. Government's System for Award Management (SAM) |
27/02/23 | 21:02 | | MILESTONE MEDICAL: The receipt of 510(k) FDA clearance for the use of CompuFlo Epidural System in thoracic indications |
24/01/23 | 17:46 | | MILESTONE MEDICAL INC. (1/2023) Dates for the Transmission of Periodical Reports in 2023 |
14/11/22 | 21:43 | | MILESTONE MEDICAL INC. (9/2022) Consolidated quarterly report for third quarter 2022 |
23/09/22 | 18:22 | | MILESTONE MEDICAL INC. (8/2022) Appointment of an entity authorised to audit financial statements for the year 2022 |
| 18:20 | | MILESTONE MEDICAL INC. (7/2022) Appointment of Directors to the Board for new term of office |
| 18:10 | | MILESTONE MEDICAL: List of Shareholders representing at least 5 % of the number of votes at the Annual General Meeting of the Shareholders on September 23, 2022 |
| 17:32 | | MILESTONE MEDICAL: Resolutions adopted by Annual General Meeting of Shareholders on September 23, 2022 |